Aptose Biosciences Stock Buy Hold or Sell Recommendation
APTO Stock | USD 1.22 0.01 0.81% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Aptose Biosciences is 'Sell'. Macroaxis provides Aptose Biosciences buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding APTO positions. The advice algorithm takes into account all of Aptose Biosciences' available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Aptose Biosciences' buy or sell advice are summarized below:
Real Value 5.83 | Hype Value 1.21 | Market Value 1.22 | Naive Value 1.15 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Aptose Biosciences given historical horizon and risk tolerance towards Aptose Biosciences. When Macroaxis issues a 'buy' or 'sell' recommendation for Aptose Biosciences, the advice is generated through an automated system that utilizes algorithms and statistical models.
Aptose |
Execute Aptose Biosciences Buy or Sell Advice
The Aptose recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Aptose Biosciences. Macroaxis does not own or have any residual interests in Aptose Biosciences or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Aptose Biosciences' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
Sell
Market Performance | Very Weak | Details | |
Volatility | Slightly risky | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Very High | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Not Available | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Aptose Biosciences Trading Alerts and Improvement Suggestions
Aptose Biosciences generated a negative expected return over the last 90 days | |
Aptose Biosciences may become a speculative penny stock | |
Aptose Biosciences has high historical volatility and very poor performance | |
Aptose Biosciences has a very high chance of going through financial distress in the upcoming years | |
Net Loss for the year was (52.15 M) with profit before overhead, payroll, taxes, and interest of 0. | |
Aptose Biosciences currently holds about 62.41 M in cash with (45.41 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.68. | |
Roughly 20.0% of the company shares are held by company insiders |
Aptose Biosciences current analysts advice
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Aptose analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Aptose analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.
Aptose Biosciences Returns Distribution Density
The distribution of Aptose Biosciences' historical returns is an attempt to chart the uncertainty of Aptose Biosciences' future price movements. The chart of the probability distribution of Aptose Biosciences daily returns describes the distribution of returns around its average expected value. We use Aptose Biosciences price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Aptose Biosciences returns is essential to provide solid investment advice for Aptose Biosciences.
Mean Return | -0.71 | Value At Risk | -5.34 | Potential Upside | 6.52 | Standard Deviation | 3.66 |
Return Density |
Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Aptose Biosciences historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Aptose Biosciences Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Aptose Biosciences or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Aptose Biosciences' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Aptose stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | -0.78 | |
β | Beta against NYSE Composite | 0.73 | |
σ | Overall volatility | 3.66 | |
Ir | Information ratio | -0.22 |
Aptose Biosciences Volatility Alert
Aptose Biosciences exhibits very low volatility with skewness of 0.9 and kurtosis of 1.35. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Aptose Biosciences' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Aptose Biosciences' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Aptose Biosciences Fundamentals Vs Peers
Comparing Aptose Biosciences' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Aptose Biosciences' direct or indirect competition across all of the common fundamentals between Aptose Biosciences and the related equities. This way, we can detect undervalued stocks with similar characteristics as Aptose Biosciences or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Aptose Biosciences' fundamental indicators could also be used in its relative valuation, which is a method of valuing Aptose Biosciences by comparing valuation metrics with those of similar companies.
Better Than Average | Worse Than Average | Compare Aptose Biosciences to competition |
Fundamentals | Aptose Biosciences | Peer Average |
Return On Equity | -2.94 | -0.31 |
Return On Asset | -1.02 | -0.14 |
Current Valuation | 11.1 M | 16.62 B |
Shares Outstanding | 15.72 M | 571.82 M |
Shares Owned By Insiders | 19.71 % | 10.09 % |
Shares Owned By Institutions | 7.60 % | 39.21 % |
Number Of Shares Shorted | 85.57 K | 4.71 M |
Price To Earning | (1.80) X | 28.72 X |
Price To Book | 3.35 X | 9.51 X |
EBITDA | (52.84 M) | 3.9 B |
Net Income | (52.15 M) | 570.98 M |
Cash And Equivalents | 62.41 M | 2.7 B |
Cash Per Share | 0.68 X | 5.01 X |
Total Debt | 1.01 M | 5.32 B |
Debt To Equity | 0.01 % | 48.70 % |
Current Ratio | 6.89 X | 2.16 X |
Book Value Per Share | (0.36) X | 1.93 K |
Cash Flow From Operations | (45.41 M) | 971.22 M |
Short Ratio | 1.08 X | 4.00 X |
Earnings Per Share | (7.58) X | 3.12 X |
Target Price | 12.0 | |
Number Of Employees | 35 | 18.84 K |
Beta | 1.42 | -0.15 |
Market Capitalization | 19.4 M | 19.03 B |
Total Asset | 12.92 M | 29.47 B |
Retained Earnings | (512.9 M) | 9.33 B |
Working Capital | (3.38 M) | 1.48 B |
Current Asset | 14.98 M | 9.34 B |
Current Liabilities | 1.7 M | 7.9 B |
Net Asset | 12.92 M |
Note: Acquisition by William Rice of 70000 shares of Aptose Biosciences subject to Rule 16b-3 [view details]
Aptose Biosciences Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Aptose . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Aptose Biosciences Buy or Sell Advice
When is the right time to buy or sell Aptose Biosciences? Buying financial instruments such as Aptose Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Aptose Biosciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Diversified Assets Thematic Idea Now
Diversified Assets
Pablicly traded close-end funds and other entities backed by different types of diversified investments. The Diversified Assets theme has 39 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Diversified Assets Theme or any other thematic opportunities.
View All Next | Launch |
Check out Aptose Biosciences Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. To learn how to invest in Aptose Stock, please use our How to Invest in Aptose Biosciences guide.You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Complementary Tools for Aptose Stock analysis
When running Aptose Biosciences' price analysis, check to measure Aptose Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aptose Biosciences is operating at the current time. Most of Aptose Biosciences' value examination focuses on studying past and present price action to predict the probability of Aptose Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aptose Biosciences' price. Additionally, you may evaluate how the addition of Aptose Biosciences to your portfolios can decrease your overall portfolio volatility.
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |
Is Aptose Biosciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aptose Biosciences. If investors know Aptose will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aptose Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Aptose Biosciences is measured differently than its book value, which is the value of Aptose that is recorded on the company's balance sheet. Investors also form their own opinion of Aptose Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Aptose Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aptose Biosciences' market value can be influenced by many factors that don't directly affect Aptose Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aptose Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Aptose Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aptose Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.